Trial Search Results
Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy
We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent maternal and neonatal complications of hyperglycemia.
Stanford is currently not accepting patients for this trial.
- Device: Dexcom Seven Plus Continuous Glucose Monitoring System
Inclusion Criteria:- 18 years of age or older
- Receiving betamethasone as part of routine clinical care.
- Pregnancy between 23+5 and 35+0 weeks
Exclusion Criteria:- Less than 18 years old.
- Major fetal anomalies
- Use of steroid medications in the past 2 weeks.
Ages Eligible for Study
18 Years - 50 Years
Genders Eligible for Study